The EUREKA cluster CELTIC-NEXT launched a call for proposals for research, development, and innovation projects related to telecommunications.

CELTIC-NEXT is a EUREKA cluster with a mission to catalyze research, development, and innovation in areas of next generation enabling telecommunications technologies and end‑to‑end services.

Open to: Small and medium-sized enterprises

Sectors of focus: Telecommunications

Key technology application areas:

• Communication technologies
• Cyber security
• Precision or smart agriculture
• Smart and connected vehicles
• Smart communities
• Other advanced manufacturing

Deadline for submission of project proposal: March 30, 2020

For more information: 2020 CELTIC-NEXT Spring Call for Proposal

The objective of the Ontario Human Capital Research and Innovation Fund (OHCRIF) is to support research and innovation projects that identify better ways to help people prepare for, return to or keep employment and become productive participants in the labour force.

The specific objectives of this funding opportunity are:

• To support implementation research teams that actively engage partners (i.e., Indigenous Peoples, community groups, decision makers and service delivery partners) as an integral part of the entire research process;
• To enhance evidence regarding the adaptation and successful implementation of evidence-based interventions (including cost-effectiveness) for the prevention and/or early diagnosis of cancer in LMICs and/or in Indigenous populations in Canada;
• To increase understanding of key barriers and facilitators (including contextual factors such as culture, governance, health systems) to cancer prevention and/or early diagnosis at local, national and/or international levels.
• To foster the incorporation of interventions into local, regional or national health policy, including their scale-up and sustainability, with a focus on equitable outcomes.

Through the Institute Community Support (ICS) Program, the CIHR Institutes and Initiatives are launching the ICS Travel Awards competition for students, postdoctoral fellows, early career researchers, and knowledge users to present their own research at national and international meetings, workshops, and/or conferences.

The specific objectives of this funding opportunity are:

• to support planning activities, partnership development and to increase understanding of the health research landscape that will contribute to the advancement of research consistent with the mandate of CIHR; and
• to support dissemination events and activities that focus on the communication of health research evidence to the appropriate researcher or knowledge-user audiences, tailoring the message and medium as appropriate

The specific objective of this funding opportunity is:

• To facilitate multinational, collaborative research projects that will address important questions related to sensory disorders and their impact on the nervous system. They may include research into all the sensory modalities including the somatosensory system and research questions addressing synergies across modalities and multisensory dysfunction.

The Operating Grants Competition is the principal means by which the Cancer Research Society (CRS) fulfills its mission to support fundamental, early translational and environment-cancer research on all types of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease. This program allows for the awarding of seed money to the most promising Canadian researchers who submit original projects related to various aspects of cancer. This investment builds on a previous partnership with CRS, and aligns with CIHR-ICR’s strategic plan while also promoting the funding of Early Career Researchers (see Eligibility). This partnership also allows CIHR-IMHA to target funds to support skin research in the area of non-melanoma skin cancers.

Research Areas

This funding opportunity will support projects relevant to the following research areas:

• Breast cancer
• All other cancer research
• Non-melanoma skin cancers